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A proposed progenitor cell for basal cell carcinoma is a stem 
cell located in the bulge of the hair follicle . Previous investi-
gations have shown that basal cell carcinoma has a specific 
stroma requirement for its growth. Likewise the develop-
ment of a normal hair follicle requires the inductive force of a 
specialized structure with condensed mesenchyme that 
eventually forms the dermal hair papilla. Investigations in 
mouse embryos also strongly indicate that induction/ growth 
of skin structures is dependent on platelet-derived growth 
factor (PDGF) a-receptor expression in the mesenchyme. 
We therefore investigated the expression of PDGF A and B 
chain and PDGF a and fJ receptors in basal cell carcinoma and 
in normal skin by immunohistochemistry and in situ hybrid-
Basal cell carcinoma (BCe) seems to have a specific and important interaction with its mesenchymal stroma. Microscopy will disclose the presence of a well-defined zone of fibroblasts around the tumor cells, with rich production of collagen especially in the morphea type 
ofBCC [1-4]. In an illuminating study of human autologous trans-
plants of BCC, van Scott showed that BCC could only grow in 
upper corium. Regression took place upon implantation in lower 
corium or subcutis [5]. This demonstrates a remarkably stringent 
requirement of a specific stroma for BCe. This demand could ex-
plain the curious absence of metastases from this in other respects 
malignant tumor, as well as its dependence on stromal factors in 
vitro [6] . 
Few molecular studies have been performed to identify potential 
participants in this stromal-epithelial interplay in BCC [7,8]. The 
attraction of such an analysis is enhanced by the possibility of com-
parisons to hair follicle development [9,10]. Morphologic observa-
tions strongly indicate that BCC arises from a cell lineage related to 
normal hair follicle development [11]. The developmental biology 
of hair formation has recently attracted renewed attention. Evi-
dence of a specific and essential interaction between mesenchyme 
and epithelium is rapidly accumulating [12]. We wanted to find out 
whether events during hair formation are reflected in the peculiar 
interrelations observed or hinted at in BCe. 
Platelet-derived growth factor (PDGF) has over the years become 
one of the most extensively investigated prototypes for control of 
multiplication and differentiation of mesenchymal elements [13] . 
An "appositional" expression of PDGF and its receptors in epithe-
lial/stromal tissues has been shown during normal embryonic de-
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ization. a and fJ receptors were found in the specific stroma 
components of basal cell carcinoma, dermal hair papilla, and 
sweat glands, but not in the epithelial structures. The A and B 
chains, on the other hand, were mainly found in basal cell 
carcinoma cells, in hair matrix, and in sweat gland epithe-
lium. This "appositional" expression of PDGF/PDGF re-
ceptor closely resembles that found in epithelial/mesenchy-
mal structures during normal development. The findings 
also suggest that PDGF receptor expression is one of the 
characteristics of the specific stroma that is necessary for basal 
cell carcinoma growth. Key words: basal cell carcinoma/platelet-
derivedgrowthfactor.} Invest DermatoI102:304-309, 1994 
velopment, including skin and hair development [14]. PDGF has 
also been shown to be directly responsible for induction of stroma in 
an experimental system [15]. In this first study of stromal-mesen-
chymal interaction in BCC, we concentrated entirely on PDGF. 
MATERIALS AND METHODS 
Tissues Fresh tumor tissue was obtained from the Department of Plastic 
Surgery at the University Hospital of Uppsala. Samples were cut, snap 
frozen, and sectioned. Cryostat sections were fixed in acetone and frozen at 
-70· C until staining. Paral1el sections were stained with hematoxylin-eosin 
for diagnosis. Twenty-six different basal cel1 carcinomas (BCe) were in-
cluded (five morphea-type, seven intermediate, five nodular, and nine su-
perficial) [4). 
Immunohistochemistry Immunohistochemistry was performed di-
rectly on cryostat sections essential1y as described [16). Acetone-fixed sec-
tions were treated with 0.3% hydrogen peroxide for 30 min to exhaust 
endogenous peroxidase activity. Avidin/biotin blocking solution (Vector 
Laboratories, Burlingame, CAl and 0.1 % bovine serum albumin (BSA) or 
2% normal horse or 10% normal goat serum were used to prevent non-
specific reactions. 
Slides were incubated at 4'C overnight with the primary antibody. 
Monoclonal antibody P~F 007 (1 : 1000) [17) and 6Dll MoAb (1: 500)[18) 
were used for Visualization of PDGF, a monoclonal antibody PDGFR-B2 
(1: .1000) for the PDGF preceptor [19), and a polyclonal affinity-purified 
an,tlserum PDGFR-7 (1 : 100) for the PDGF a receptor [20) . After washing 
With phosphate-buffered salllle (PBS), the slides were incubated at room 
temperature for 30 min with biotinylated horse anti-mouse immunoglobu-
lin (Ig)G or goat anti-rabbit IgG as secondary antibody. The immunoreac-
tion was detected by avidin/biotin complex (Vector or Dakopatts) with 
0.04% hydrogen peroxide as substrate and 3-amino-9-ethylcarbazole as a 
chromogen. Hematoxylin-eosin was used for counterstaining. Photographs 
were taken in a Zeiss, Axioskop microscope using a Sony DXC-M2 video-
camera connected to Sony color videoprinter system. 
111 Situ Hybridization Twelve cases were examined (five morphea-type, 
two intermediate, two nodular, and three superficial). I" sitll hybridization 
was performed essentially as described [16,21,22). Routine formalin-fixed 
paraffin-embedded sections were dewaxed and digested with 0.1 mg/ml 
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Figure 1. Immunohistochemistry with antibodies to PDGF receptors and PDGF shows PDGF receptors in the Bee stroma and PDGF mainly in Bee cells 
as well as in normal hair follicle epithelium. PDGF a receptor staining of normal.s~in sh<;>ws a ~ew I'0sitive cells in the papillary derrnis (A) whereas in Bee, 
positive staining is found on most mesenchymal cells in the tumor stroma (B) . Stau:ung wIth. antl?odles to the PDGF preceptor shows a similar pattern (e,D). 
High magnification of a normal anagen hairbulb visualizes strong positive statnmg of epIthelIal cells in the matrix area (E). Bee stained with the same 
antibody (PGF 007) shows positive staining in Bee cells (F). Staining with antibody PGF 007 was blocked by preincubation with PDGF BB (not shown). 
Staining of tissue sections without addition of any primary antibody gave completely negative resu lts . Transfected cells used as positive controls showed 
reactivity with the respective antibodies, whereas untrallSfected cells were negative or weakly positive (not shown). A - E) bar, 30 nun; F) bar, 100 mm. 
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Figure 2. III situ hybridization visualizing PDGF a receptor and PDGF A mRNAs in normal skin and in BCC. PDGF a receptor was seen in dermal hair 
papilla cells and in the BCC stroma cells whereas PDGF A was seen mainly in epithelial cells of epidermis, hair follicles, and BCC cells. In normal skin the 
PDGF a receptor probe labeled some mesenchymal celJs in papillary dermis (A, B) and was strong in dermal hair papilla cells (D). In BCC PDGF a 
receptor-positive cells are seen in the stroma adjacent to tu.mor cells (E). In normal skin the PDGF A probe: shows low labeling in epider.mal keratinocytes (C) 
and higher Signals 111 epithelial cells of the anagen hau follicle (F). In BCC, PDGF A probe shows labeling Ul the tumor cells and III occasIOnal stroma cells (G). 
In sitll hybridizations with PDGF preceptor and PDGF B probe show a similar pattern of expression as PDGF a receptor and PDGF A in normal skin as well as 
in BCC (not shown). A,C-G) bar, 30 mm; B) bar, 14 mm. 
proteinase K (Sigma Chemicals, Inc., St. Louis, MO). 35S-labeled RNA 
probes were synthesized ill vitro ftom plasmids containing the following 
human cDNAs: 1.5-kilobase (kb) Eco RI-Pst I fragment of a PDGF a recep-
tor cDNA [20], 1-kbPst I fragment of a cDNA corresponding to the external 
domain of the PDGF preceptor [23], 1.3-kb Eco RI fragment of cDNA for 
PDGF A chain [24], and 2-kb Bam HI fragment of a PDGF B chain cDNA 
[25], all subcloned in pGEM-3Z vector [16]. Exposure time was 2 weeks and 
Mayers hematoxylin-eosin was used for counterstaining. Photographs were 
taken in a Zeiss, Axioskop microscope using a Sony DXC-M2 videocamera 
connected to Sony videoprinter system. 
Controls 35S-labeled RNA probes transcribed from the pGEM-3Z vector 
without any insert were used to estimate background signalling. Pretreat-
ment with RNase A of tissue slides and omission of probe hybridization 
served as additional negative controls. All tissue sections were checked for 
presence of cellular mRNA by hybridization with the human p actin RNA 
probe transcribed from a 1.9-kb Bam HI eDNA fragment inserted in a pSP65 
vector. As control cells for specific hybridization signals, we used porcine 
aorta endothelial (PAE) celJs transfected with PDGF a or p receptor con-
structs (kindly ptovided by Dr. L. Claesson-Welsh and Dr. A. Eriksson at the 
Ludwig Institute for Cancer Research BMC, Uppsala, Sweden) and Chinese 
hamster ovary (CHO) cells transfected with PDGF A or B chain constucts 
(kindly provided by Dr. A. Ostman at the same institute). These controls 
showed that there was no cross-hybridization between the PDGF a and p 
receptor probes or between the PDGF A and B chain probes. 
RESULTS 
PDGF Receptors Immunohistochemistry in normal skin 
showed only weak staining with the anti-PDGF P receptor anti-
body and the anti-PDGF IX receptor antiserum. Positive staining 
was seen in scattered cells of the papillary dermis (Fig lA, C), around 
hair follicles and in cells of the sweat gland stroma (data not shown). 
In BCC there was a positive staining of the fibroblastic stroma cells 
surrounding the BCC nests. This pattern was seen both with the 
anti-PDGF P receptor antibody and the anti-PDGF IX receptor 
antiserum (Fig 1B,D). There was no staining of epithelial cells. 
High ill situ hybridization signals with the PDGF receptor probes 
were seen in the normal skin only in the cells of the dermal hair 
papilla and cells of the stroma surrounding sweat gland coils. Espe-
cially the cells of the dermal hair papilla showed a strong hybridiza-
tion with the IX receptor probe (Fig 2D) and a somewhat weaker 
reaction with the P receptor probe (not shown). The sweat gland 
stroma cells seemed to be equally positive for both receptors (Fig 
3A,B). Scattered positive cells of unidentified nature, but with a 
mesenchymal phenotype, were seen in a close sub-epidermal posi-
tion (Fig 2A,B) and in the loose connective tissue surrounding hair 
follicles. In BCC ill situ hybridization showed a similar general 
pattern as the immunohistochemistry. A high proportion of cells in 
the specialized stroma surrounding BCC cells expressed PDGF IX 
and preceptor mRNA (Fig 2E and not shown). There was no clear 
difference between the pattern of hybridization with the two recep-
tor probes. The positive cells showed a fibroblastic phenotype and 
were mostly localized adjacent to the BCC nests. Receptor-positive 
cells were also seen in and around the walls of newly formed capil-
laries. We found no obvious difference in the different histologic 
types of BCC and there was no hybridization of the receptor probes 
to the RNA of basalioma cells. 
PDGF Immunohistochemistry using antibodies PGF 007 and 
6D11 MoAb stained normal skin and the epidermis adjacent to and 
overlying the BCe. Strongly staining cells were seen with the dis-
tribution and morphology of Langerhans cells, whereas keratino-
cytes were only weakly positive (not shown). Large amounts of 
PDGF in epithelial cells were only visualized in the germinative 
cells of the hair matrix region (Fig 1E). In BCC, the epithelial 
tumor cells showed an uneven staining with negative or very weak 
reactions in the upper parts and stronger staining in the deeper parts 
of the tumor when the PGF 007 antibody was used (Fig 1F). Scat-
tered cells like the ones in epidermis (see above), with much 
stronger staining than in keratinocytes, were found in the tumor cell 
nests (not shown). A few positive cells were seen in the stroma 
around the tumor. The PGF 007 staining was to a large part inhib-
ited by preincubation of the antibodies with human recombinant 
PDGF BB (not shown), which assures that the staining specifically 
visualized PDGF in the tissues. 
II! situ hybridization showed that PDGF A mRNA was present in 
hair epithelia, mainly in the cells adjacent to the dermal hair papilla 
(Fig 2F) and in sweat gland coils, where hybridization was seen both 
in stroma and epithelial cells of the sweat glands (Fig 3C). Weakly 
labeled cells were also seen in the epidermis without any obvious 
concentration on Langerhans cells (Fig 2C). Labeling was found in 
smooth muscle cells of the vessel walls (not shown). PDGF B 
mRNA followed the same pattern as PDGF A but with generally 
weaker signals (not shown and [30]). In BCC, PDGF A mRNA was 
found mainly in the BCC cells, where it was evenly dispersed (Fig 
2G). Overlying normal epidermis and the surrounding hair follicles 
were labeled as described above. In the stroma, a few positive cells 
could be detected, at least in part representing vascular or perivascu-
lar cells (not shown). PDGF B mRNA was more inconspicuous and 
a weak reaction was seen with the same distribution pattern as for 
PDGF A (not shown). 
The results of the irl situ hybridization and immunohistochemis-
try are summarized in Table I. The patterns of immunoreactivity for 
the two types ofPDGF receptors were virtually identical to those of 
their respective mRNA~. Receptors were not found in the epithe-
lium, but were predoml11antly present in the specific stroma com-
ponents ofBCC nests, dermal hair papillae, and sweat glands. The A 
and B chains of PDGF followed the same basic pattern, i.e., con-
comitant expression in hair root, sweat gland, and BCC epithelium. 
Thus, the PDGF/PDGF receptor system was identically expressed 
in BCC, ha.ir follicles, and sweat glands. Normal epidermis and its 
loose subepidermal stroma showed a similar pattern, but with more 
dispersed mesenchymal cells and weaker signals. 
DISCUSSION 
The epithelial cells of the BCC synthesized both A and B chains of 
the PDGF molecule as evidenced by the presence of their respective 
mRNAs. Signals for rhe A chain were generally somewhat stronger, 
but we do not know if this reflects technical factors or if there is, 
indeed, relative overproduction of A message. Receptors for PDGF 
were absent in the epithelial cells themselves. The locally closest 
PDGF receptors were found in small patches of fibroblast-like cells 
in the stroma immediately apposed to the BCC cells. The receptors 
were of both IX and P type. The prerequisites are thus present for 
local stimulation by the BCC cells ofloca! stroma fibroblasts, which 
in turn may be essential for the epithelial cells in maintaining their 
status as undifferentiated multiplying elements. 
The scheme outlined above seems to be a general one, possibly 
essential for growth ofBCC, because the same pattern was found in 
all cases of BCC including some very small tumor nests apparently 
at a very early stage of their development. 
The "appositional expression" ofPDGF and PDGF receptors in 
tumor and stromal cells has previously been noted in human glio-
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Figure 3. If! sitll hybridization visualizing PDGF mainly in epithelial cells and PDGF receptors in stroma cells of normal adult sweat glands. Labeling is 
present both with the PDGF a receptor (A) and with the PDGF P receptor probe (B) in stromal cells lying i~mediately adjacent to the sweat gland epithelium. 
Hybridization with PDGF A and B probes shows labeling in sweat gland epithelial cells and to some extent In sweat gland stroma cells (C andD, respectively). 
Bar, 14 mm. 
mas [16] and mammary carcinomas.· The increased expression of 
PDGF receptors in the stroma of epithelial tumors seems to be a 
general phenomenon [26,27]. "Appositional expression" has also 
been described as a general phenomenon occurring during normal 
development where inductive events take place [14,28,29]. 
It was of special interest to compare the pattern of expression in 
BCC with that in developing hair follicles. The finding was a strik-
ing resemblance between the PDGF and PDGF receptor patterns 
when hair epithelium and its dermal papilla stroma were compared 
to nests of BCC and their connective tissue stroma. Both epithe-
lium/stromal systems showed synthesis ofPDGF and the presence 
of specific receptors both after immunohistochemistry and in situ 
hybridization for specific mRNAs. This provides strong evidence 
for a close cell biologic relation between the hair follicle appara-
tus and BCe. The same pattern of PDGF and PDGF receptor ex-
pression was seen in the epithelial/stromal components of 
the sweat glands. The functional significance of this finding is 
unknown. 
Cancer stroma has generally been r~garded as a "non-specific" 
feature of malignant neoplasia. The presence of mesenchyme in 
epithelial cancer is necessary for the viability of the cancer cells. 
This has generally been conceived of as a passive effect of blood 
• Ren Z, Aurivillius M, Funa K, Lindgren A, Ponten J, Nister M, Valver-
ius EM: Expression of the PDGF receptors and ligands in human breast 
cancer indicates a paracrine function (manuscript in preparation). 
supply. In BCC the interaction between stroma and epithelium 
seems much more specific, as it closely mimics the conditions of the 
corresponding normal system-the hair follicle-at least with re-
gard to PDGF. 
Interestingly, we found that spots in the upper part of the corium 
in normal skin contained mesenchymal cells with PDGF receptor 
expression. PDGF receptor expression might therefore be one of 
the necessary characteristics of a BCC-permissive stroma. Possibly 
such stroma could indicate the sites at which BCC can arise outside 
of hair follicles. 
These findings suggest that basal cell carcinoma does not arise 
because of a disturbance of the para- (and autocrine?) functions of 
PDGF. The primary lesion(s) that make it possible for BCC cells to 
behave neoplastic ally are still unknown. The consistent findings of 
PDGF production by BCC and the presence of cognate stroma 
receptors in a large series of BCC representing all known morpho-
logic types, however, imply that the growth of BCC could be de-
pendent on the PDGF/PDGF receptor interplay. Studies on mouse 
embryos homozygous for a deletion of the PDGF a receptor gene 
strongly imply that induction/growth of skin structures is depen-
dent on PDGF a receptor expression [28,29]. PDGF is also involved 
in the healing of skin wounds [30-32]. A prediction would be that 
interruption of the paracrine PDGF interrelation would lead to 
regression of BCe. 
The finding of a close relationship between the control of 
growth and differentiation in hair follicles and BCC opens up pos-
sibilities of understanding fundamental features of neoplasia as 
well as analyzing aspects of normal hair and skin develop-
ment. 
VOL. 102, NO. 3 MARCH 1994 THE PDGF SYSTEM 309 
Table I. PDGF in Skin and Basal Cell Carcinoma' 
Normal Skin Sweat Glands BCC 
Dermal Hair 
PDGF Epidermis Papillary Dermis Hair Epithelium Papilla Cells Epithelial Cells Stroma Cells BCC Cells Stroma Cells 
a receptor (+) 
preceptor (+) 
A chain + ++ 
B chain (+) + 
++ 
+ 
(+) + 
(+) + 
++ 
+ 
(+) 
(+) 
++ 
+ 
++ 
++ 
(+) 
(+) 
• Overview of results obtained by immunohistochemistry and i" situ hybridization pointing out the virtually identical pattern ofPDGF /PDGF receptor expression found in normal 
hair follicles and BCe. 
The work was supported by grams from the Swedish CatlCer FO/ltldaliotl to JaIl 
Ponten, Monica Nister, and BetJgt Westermark. 
We thank Car/-HetJrik Heldin, Keiko Funa, and Flemming Vassbotn for getJer-
ollsly sllpplying atltibodies and probes. We also thatlk Monica Hermansotl, Erik 
Borlgcam-Rudloff, and Su Huici for vaillable techllical advice. 
REFERENCES 
1. Miller SJ: Biology of basal cell carcinoma (part I).] Am Acad Dermato/24(1 ):1-13, 
1991 
2. Miller S]: Biology of basal cell carcinoma (part U). ] Am Acad Dermatol 
24(2):161 -175,1991 
3. Moy RL, Moy LS, Matsuoka L Y, Bennett RG, Uitto J: Selectively enhanced 
procollagen gene expression in sclerosing (morphea-like) basal cell carcinoma 
as reflected by elevated pro a (I) and pro a (III) procollagen messenger RNA 
steady-state levels. ] ["vest Dermatol 90:634 - 638, 1988 
4. Lever WF, Schaumberg-Lever G: Histopathology of the Ski", 7th ed. J.B. Lippincott 
Company, Philadelphia, 1990, p 940 
5. Scott E]V, Reinertson RP: The modulating influence of stromal environment on 
epithelial cells studied in human autotransplants.] ["vest Dermato/36: 1 09 - 117, 
1961 
6. Hernandez AD, Hibbs MS, Postlethwaite AE: Establishment of basal cell carci-
noma in culture: evidence for a basal cell carcinoma-derived factor(s) which 
stimulates fibroblasts to proliferate and release collagenase.] ["vest Dermatol 
85:470-475,1985 
7. Bradbeer M, Bourne A], Ayberk H, T ang SK, Marks R: Growth and antigenic 
characteristics of basal cell carcinoma in culture. Arch Dermatol Res 280:228-
234, 1988 
8. Grimwood RE, Ferris CH, Nielsen LD, Huff ]C, Clark RAF: Basal cell carcino-
mas grown in nude mice produce and deposit fibronectin in the extracellular 
matrix.] bJVesr Dermato/87:42-46, 1986 
9. Goodman LV, Ledbetter SR: Secretion of stromelysin by cultured dennal papilla 
cells: differential regulation by growth factors and functional role in mitogen-
induced cell proliferation.] Cell Physio/151:41 - 49, 1992 
10. Lyons KM, Pelton RW, Hogan BLM: Organogenesis and pattern fonnation in 
the mouse: RNA distribution patterns suggest a role for Bone Morphogenic 
Protein-2A (BMP-2A). Developmwt 109:833 -844, 1990 
11. Cotsarelis G, Sun T-T, Lavker RM: Label-retaining cells reside in the bulge area 
of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin 
carcinogenesis. Cell 61:1329-1337, 1990 
12. Hardy MH: The secret life of the hair follicle. Tre"d Ge"et8(2) :55-61, 1992 
13. Westermark B: The molecular and cellular biology of platelet-derived growth 
factor. Acta E"docri"oI123:131-142, 1990 
14. Orr-Urtreger A, Lonai P: Platelet-derived growth factor-A and its receptor are 
expressed in separate, but adjacent cell layers of the mouse embryo. Deve!opmwt 
115:1045-1058,1992 
15. Forsberg K, Valyi-Nagi I, Heldin C-H, Hetlyn M, Westermark B: Platelet-de-
rived growth factor C (PDGF) in oncogenesis: development of a vascular 
connective tissue stroma in xenotransplanted human melanoma producing 
PDGF BB. Proc Natl Acad Sci USA 90:393-397, 1993 
16. Hermansson M, Funa K, Hartman M, Claesson-Welsh L, Heldin C-H, Wester-
mark D, Nister M: Platelet-derived growth factor and its receptors in human 
glioma tissue: expression of messenger RNA and protein suggests the presence 
of autocrine and paracrine loops. Ca"cer Res 52:3213-3219,1992 
17. Shiraishi T, Morimoto S, Itoh K, Sato H, Sugihara K, Onishi T, Ogihara T: 
Radioimmunoassay of human platelet-derived growth factor using monoclonal 
antibody toward a synthetic 73-97 fragment of its D-chain. ClitJ Chim Acta 
184:65- 74, 1989 
18. Vassbotn F, Langeland N, Hagen i , Holmsen H: A monoclonal antibody against 
PDGF B-chain inhibits PDGF induced DNA synthesis in C3H fibroblasts and 
prevents binding ofPDGF to its receptor. Biochim Biophys ACla 1054:246-249, 
1990 
19. Ronnstrand L, Terracio L, Claesson-Welsh L, Heldin C-H, Rubin K: Character-
ization of two monoclonal antibodies reactive with the external domain of the 
platelet-derived growth factor receptor.] BioI Chem 263(21):10429-10435, 
1988 
20. Claesson-Welsh L, Eriksson A, Westermark B, Heldin C-H: eDNA cloning and 
expression of the human A-rype platelet-derived growth factor (PDGF) recep-
tor establishes structural similariry to the B-rype PDGF receptor. Proc Nat! Acad 
Sci USA 86:4917-4921, 1989 
21. Funa K, Steinholtz L, Nou E, Bergh J: increased expression ofN-myc in human 
small cell lung cancer biopsies predicts lack of response to chemotherapy and 
poor prognosis. Am] Patlro/88:216-220, 1987 
22. Hermansson M, Nistor M, Betsholtz C, Heldin C-H, Westermark E, FUlla K: 
Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA 
for platelet-de.rived growth factor (PDGF) B-cllain and PDGF receptor sug-
gests autocrine growth stimulation. Proc Natl Acad Sci USA 85:7748-7752, 
1988 
23. Claesson-Welsh L, Eriksson A, Moren A, Severinsson L, Ek B, Ostman A, Bet-
sholtz C, Heldin C-H: eDNA cloning and expression of a human platelet-der-
ived growth factor (PDGF) receptor specific for B chain-containing molecules. 
Mol Cell BioI 8:3476-3486, 1988 
24. Betsholtz C,]ohnsson A, Heldin C-H, Westermark B, Lind P, Urdea MS, Eddy 
R, Shows TB, Philpott K, Mellor AL, Knott TJ , Scott]: eDNA sequence and 
chromosom.l localization of human platelet-derived growth factor A-chain 
and its expression in tumor cell lines. Nawre 320:695-699,1986 
25. Clarke MF, Westin E, Schnidt D, Josephs SF, Ratner L, Wong-Staal F, Gallo RC, 
Reitz MS ]r: Transformation of NIH 3T3 cells by a human c-sis eDNA clone. 
Natllre 308:464-467, 1984 
26. Funa K, Papanicolaou V,Juhlin C, Rastad], Akerstrom G, Hddin C-H, Oberg K: 
Expression of platelet-derived growth factor beta receptor on stromal tissue 
cells in human carcinoid tumors. CatJcer Res 50:748-753, 1990 
27. Chaudhry A, Papanicolaou V, Oberg K, Heldin C-H, FUlla K: Expression of 
platelet-derived growth factor and its receptors in neuroendocrine tumors of 
the digestive system. Callcer Res 52:1006-1012, 1992 
28. Schatteman GC, Morrison-Graham K, Koppen AV, Weston JA, Bowen-Pope 
DF: Regulation and role of PDGF receptor alfa-subunit expression during 
embryogenesis. Developmellt 115:1 23-131 , 1992 
29. Orr-Urtreger A, Bedford MT, Do M-S, Eisenbach L, Lonai P: Developmental 
expression of the alfa receptor for platelet-derived growth factor, which is 
deleted in the embryonic lethal patch mutation. Developrnelll 115:289-303, 
1992 
30. Majesky MW, Reidy MA, Bowen-Pope DF, Hart CE, Wilcox IN, Schwartz SM: 
PDGF ligand and receptor gene expression during repaitofarterial injury.] Cell 
BioI 111:2149-2158, 1990 
31. Antoniades HN, Galanopoulos T , Neville-Golden], Kiritsy CPo Lynch SE: [n-
jury induces in vivo expression of platelet-derived growth factor (PDGF) and 
PDGF receptor mRNAs in skin epithelial cells and PDGF mRNA in connec-
tive tissue fibroblasts . Proc Nat! Acad Sci USA 88:565 - 569, 1991 
32. Robson M, Phillips L, Thomason A, Robson L, Pierce G: Platelet-derived growth 
factor BB for the treatment of chrollic pressure ulcers. La "cet 339:23- 25, 1992 
